6867. Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
作者: Mattia Galli.;Stefano Benenati.;Davide Capodanno.;Francesco Franchi.;Fabiana Rollini.;Domenico D'Amario.;Italo Porto.;Dominick J Angiolillo.
来源: Lancet. 2021年397卷10283期1470-1483页
Whether guided selection of antiplatelet therapy in patients undergoing percutaneous coronary intervention (PCI) is effective in improving outcomes compared with standard antiplatelet therapy remains controversial. We assessed the safety and efficacy of guided versus standard selection of antiplatelet therapy in patients undergoing PCI.
6868. Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)-non-inferiority (peripheral arterial catheter) trial.
作者: Claire M Rickard.;Nicole M Marsh.;Emily N Larsen.;Matthew R McGrail.;Nicholas Graves.;Naomi Runnegar.;Joan Webster.;Amanda Corley.;David McMillan.;John R Gowardman.;Debbie A Long.;John F Fraser.;Fenella J Gill.;Jeanine Young.;Marghie Murgo.;Evan Alexandrou.;Md Abu Choudhury.;Raymond J Chan.;Nicole C Gavin.;Azlina Daud.;Annamaria Palermo.;Adrian Regli.;E Geoffrey Playford.
来源: Lancet. 2021年397卷10283期1447-1458页
The optimal duration of infusion set use to prevent life-threatening catheter-related bloodstream infection (CRBSI) is unclear. We aimed to compare the effectiveness and costs of 7-day (intervention) versus 4-day (control) infusion set replacement to prevent CRBSI in patients with central venous access devices (tunnelled cuffed, non-tunnelled, peripherally inserted, and totally implanted) and peripheral arterial catheters.
|